| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.7 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |